Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Bayer AG | 16 | 3 | 3 | 2 | €27.38 | €45.00 | 64.354% |
| Merck KGaA | 3 | 2 | 0 | 1 | €161.50 | €146.00 | -9.598% |
| Eli Lilly Corp. | 62 | 1 | 7 | 1 | €741.50 | €824.47 | 11.189% |
| Incyte Corp. | 13 | 2 | 1 | 1 | €63.20 | €77.67 | 22.898% |
| Roche Holding AG ADR | 2 | 2 | 0 | 0 | €37.56 | €38.00 | 1.176% |
| Novo Nordisk A/S ADR | 20 | 1 | 1 | 0 | €117.00 | €144.02 | 23.093% |
| Teva Pharmaceutical Industries Ltd ADR | 17 | 0 | 2 | 0 | €15.80 | €18.95 | 19.934% |
| Amgen Inc. | 25 | 0 | 1 | 0 | €308.45 | €304.65 | -1.233% |
| Biogen Inc. | 51 | 1 | 4 | 0 | €194.45 | €291.49 | 49.906% |
| GSK plc ADR | 6 | 0 | 1 | 0 | €36.80 | €49.33 | 34.041% |
| Sanofi S.A. | 3 | 0 | 0 | 0 | €96.21 | €99.50 | 3.420% |
| Gilead Sciences Inc | 11 | 1 | 1 | 0 | €70.94 | €85.27 | 20.206% |
| Pfizer Inc. | 28 | 4 | 1 | 0 | €28.35 | €41.47 | 46.312% |
| AbbVie Inc. | 33 | 0 | 9 | 0 | €170.56 | €178.59 | 4.709% |
| Novartis AG ADR | 3 | 0 | 1 | 0 | €102.00 | €112.40 | 10.194% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €136.05 | €130.00 | -4.447% |
| Sanofi S.A. ADR | 11 | 0 | 2 | 0 | €48.40 | €55.25 | 14.161% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €143.80 | €165.00 | 14.743% |
| Merck & Co. Inc. | 30 | 1 | 0 | 0 | €115.40 | €124.97 | 8.296% |
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
| Abbott Laboratories | 19 | 0 | 1 | 0 | €96.93 | €116.25 | 19.929% |
| UCB S.A. | 1 | 0 | 0 | 0 | €152.65 | - | - |
| Vertex Pharmaceuticals Inc. | 55 | 2 | 4 | 0 | €456.30 | €450.36 | -1.301% |
| Grifols S.A. | 1 | 0 | 0 | 0 | €9.13 | - | - |
| Ipsen S.A. | 1 | 0 | 0 | 0 | €103.90 | €109.00 | 4.909% |